Renal denervation therapy: A device based approach for HTN management

Renal denervation therapy: A device based approach for HTN management

A badge with ribbon in color black Point(s): 1 | An analog clock in color black 19 minutes | A black calendar with white triangle in center that has a black exclamation point in the middle 11 Nov 2022 


Hypertension (HTN) remains a principal cause of premature death worldwide. The goal of this learning activity is to provide doctors with a comprehensive review of renal denervation therapy (RDN) and its role in improving BP control in patients with HTN. Upon completing this module, participants will have a better understanding of the following aspects:

. Epidemiology and burden of HTN

. The role of RDN in managing HTN

. Current treatment options for HTN

. Guidelines and recommendations

CPD Reviewer:

Datin Prof Dr Chia Yook-Chin

Department of Medical Sciences, Sunway University

Department of Primary Care Medicine, University of Malaya

Who should participate:

• Doctors


Please watch the video before attempting the assessment questions.

Terms & Conditions:

Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point.

MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD point

To play this video, you are required to have a media player such as Windows Media Player (PC), QuickTime (MAC) or another third party media player.

Sponsored by: